Daiichi Sankyo’s mission is to create innovative medicines that improve people’s health and quality of life. Our European research and development operations are an integral part of our global R&D activities. To reinforce the competitiveness of research in the disease areas which have high unmet medical needs, we focus our resources on cardiovascular-metabolics and oncology as the priority discovery areas.